SHANGHAI HI SILICON TECHNOLOGY CO., LTD.
SHANGHAI HI SILICON TECHNOLOGY CO., LTD.

NMN Beta: What Are the New Trends & Shifts in the Global Market? What Measures Should Buyers Take to Seize Opportunities & Address Challenges Brought by Market Changes?

Table of Content [Hide]

    As a new type of foreign trade service provider driven by dual engines of technology transformation and export services, HiSiaddi has built a "1+2+3+4=1" service system and can supply original factory sources of multiple well-known NMN Beta brands.

    Driven by its "1+1>2" business model that integrates technology transformation and export development, HiSiaddi consistently tracks the global NMN Beta market from both scientific research and commercial perspectives. Today, we conduct a professional analysis of new shifts and trends in the global NMN Beta market.

    If you require more comprehensive, valuable market intelligence on NMN Beta, please contact HiSiaddi customer service.

    I. Five Core New Trends of the Global NMN Market (2025–2026)

    (1) Global Rollout of Regulatory Compliance & Standardized Market Access Thresholds

    Major global markets have finalized compliance validation for NMN, eliminating grey market operations:

    · The US FDA recognizes NMN as a legal dietary supplement raw material with GRAS certification;

    · Australia’s TGA has included NMN in its complementary medicine list;

    · Japan’s Ministry of Health, Labour and Welfare and Health Canada have concurrently acknowledged its classification as food/supplement.

    In China, NMN was added to the health food approval catalog in 2025. Starting June 2026, Customs Decree No. 280 will take effect, mandating China registration and Chinese label filing for all imports, with cross-border e-commerce emerging as the core sales channel (accounting for 60%–70% of total volume).

    Core change: Compliance has evolved from a competitive advantage to a mandatory entry ticket. Products lacking certification, with mislabeled ingredients or false marketing claims are fully removed from the market, forming a global regulatory landscape featuring mutually recognized certifications and unified standards.

    (2) Explosive Market Growth, Hierarchical Demand & Diversified Application Scenarios

    The global NMN supplement market reached approximately RMB 10.28 billion in 2025 and is projected to surpass RMB 39 billion in 2026, with a compound annual growth rate (CAGR) of 32.5% — far exceeding the 6.99% growth rate of the global anti-aging market. China contributes over 36% of global market growth and accounts for 24.1% of the global anti-aging supplement sector.

    Demand segmentation:

    · Seniors aged 60+: Prioritize anti-aging and metabolic regulation;

    · Working professionals aged 25–45: Focus on early anti-aging, energy boost and sleep improvement;

    · Consumers under 30: Make up nearly 40% of buyers, targeting daily wellness and skin anti-aging.

    Expanded application scenarios: NMN usage has expanded from standalone health supplements (86.5% of total consumption) to cosmetics (11.2%), pet nutrition, medical rehabilitation, agricultural stress resistance and other vertical sectors.

    (3) Technological Iteration Drives Cost Reduction, with Purity & Bioavailability Becoming Core Competitive Differentiators

    Synthetic production has shifted from chemical synthesis to dominant full enzymatic processes, cutting production costs by 50%. Global retail prices are expected to drop to 70% of current levels by 2026, with large-scale production facilities (e.g., GeneHarbor’s 50-ton annual capacity, Bontac’s 150-ton annual capacity) further lowering unit prices.

    Key technological focal points:

    1. Purity upgrade: Industry standards have risen from 98% to 99.5%–99.9%, with high-purity products (≥99.5%) accounting for 45% of total supply;

    2. Delivery technology breakthroughs: Microencapsulation, liposomal wrapping and sustained-release technologies raise oral bioavailability from the industry average of 22.4% to above 38%;

    3. Clinical evidence as standard practice: Leading brands have launched Phase III clinical trials to validate efficacy with empirical data.

    (4) Restructured Supply Chain Landscape: China Dominates Raw Materials, Japan & South Korea Control High-End Formulations

    China supplies over 65% of global NMN raw materials, exporting 285 tons in 2023. Core manufacturers (GeneHarbor, Kingdomway, Bontac Biotech) operate full-industry-chain production with purity ≥99.5% and hold FDA GRAS, EU Novel Food and other global certifications.

    Japanese brands (e.g., Shinwa) and US brands (e.g., Herbalmax) focus on premium finished formulations. Leveraging refined formulations and accumulated clinical data, their products command unit prices 3–5 times higher than equivalent Chinese goods, monopolizing high-end markets in Europe and America.

    Core shift: Supply chain competition has moved beyond low-cost raw material price wars to integrated competition covering raw materials, proprietary technology and brand equity. Chinese enterprises are accelerating transformation from raw material suppliers to proprietary brand owners.

    (5) Competition Shifts from Price Wars to Value Competition; Brand Premium & Compliance Endorsement Are Critical

    The industry has exited unregulated rapid expansion. The top five enterprises capture 75% of global market share, with competition no longer centered on price or ingredient dosage but purity, absorption efficiency, clinical validation and compliance credentials.

    Consumers now prioritize brand certifications, transparent ingredient disclosures and proven efficacy. The high-end segment (products priced ≥USD 500 per bottle) grows at 40%, vastly outpacing the mass market’s 15% growth rate.

    Core change: Uncertified, technologically deficient brands lacking clinical backing are rapidly phased out, while enterprises with full compliance credentials, technical barriers and established brand influence dominate the market.

    II. Differentiated Challenges & Opportunities for Downstream B2B Buyers (Health Supplement / Cosmetic / Pet Nutrition / Cross-Border E-Commerce Operators)

    (1) Health Supplement Brands (Core Downstream Segment, 86.5% of Total Consumption)

    Core Challenges

    1. Soaring compliance costs: Entering European and US markets requires FDA GRAS and EU Novel Food certifications, costing over USD 500,000 per brand with a 6–12 month approval timeline;

    2. Severe homogenized competition: Low-tier NMN products feature identical ingredients and claimed effects, with price wars squeezing gross profit margins from 30% to below 15%;

    3. Unstable supply chains: Fluctuating raw material purity, insufficient production capacity and 2–4 week lead times disrupt end-product manufacturing and delivery schedules;

    4. Difficulty building consumer trust: Widespread false marketing makes consumers skeptical of efficacy, steadily increasing customer acquisition costs year over year.

    Core Opportunities

    1. Blue ocean high-end market: High-purity (≥99.5%), high-absorption (≥38%) products supported by clinical data deliver substantial premium margins of 50%–80%;

    2. Booming segmented demand: Differentiated products targeting senior anti-aging, workplace energy restoration and female early anti-aging easily stand out amid market competition;

    3. Dividends from China’s supply chain: Abundant domestic raw material capacity delivers cost advantages and shortens delivery lead times to 7–14 days.

    (2) Cosmetic Brands (Second-Largest Downstream Segment, 11.2% of Total Consumption)

    Core Challenges

    1. Poor formulation compatibility: NMN is highly water-soluble and chemically unstable, prone to discoloration and efficacy loss under temperature and pH fluctuations, requiring specialized formulation technology;

    2. Divergent compliance standards: Cosmetic-grade NMN must meet EU ECOCERT and US USP criteria, with distinct purity and impurity control requirements separate from supplement-grade NMN;

    3. Barriers to efficacy validation: Human clinical trials for skin anti-aging and repair effects are lengthy and capital-intensive, unaffordable for small and medium-sized brands.

    Core Opportunities

    1. Dual-track internal + external consumption: NMN delivers anti-aging, skin repair and brightening benefits, supporting development of serums, creams, masks and other topical products that pair synergistically with oral supplements to boost average order value;

    2. Premium beauty product markup: High-purity NMN-infused anti-aging skincare commands a 30%–50% price premium, aligning with rising demand for luxury beauty goods.

    (3) Pet Nutrition Brands (Emerging Downstream Segment, 40%+ Annual Growth Rate)

    Core Challenges

    1. Lack of unified industry standards: No global standardized specifications for pet-grade NMN, with undefined benchmarks for purity, recommended dosage and safety, creating risks of inconsistent product quality;

    2. Low consumer awareness: The pet NMN market remains in its infancy, incurring high market education expenses to drive consumer recognition.

    Core Opportunities

    1. High-growth blue ocean market: The global pet health market exceeds USD 100 billion. NMN alleviates pet aging, joint deterioration and poor coat health, with rapidly rising end-user demand;

    2. Low competitive pressure: Few market participants and no dominant industry leaders, allowing small and medium brands to quickly capture market share.

    (4) Cross-Border E-Commerce & Trading Companies (Core Distribution Channel, 60%–70% of End Sales Volume)

    Core Challenges

    1. Elevated inventory risks: NMN prices fluctuate 10%–15% quarterly, exposing bulk purchasers to losses from price declines; low-turnover SKUs and high-purity variants tie up capital in slow-moving stock;

    2. Strict channel compliance rules: European and US cross-border platforms (Amazon, eBay) enforce rigorous audits of product certifications and label specifications, with violations resulting in immediate store delistings;

    3. Price transparency compresses margins: Online price comparison tools intensify low-price competition, eroding profit margins for intermediaries.

    Core Opportunities

    1. Global market integration: Cross-border channels enable operators to connect small and medium overseas brands with China’s premium raw material supply base, generating revenue from product margins and service fees;

    2. Dividends from differentiated product selection: Curating certified, clinically validated high-purity products avoids low-price red oceans and improves profit margins.

    III. Four Targeted Competitiveness-Boosting Strategies for Downstream B2B Buyers

    (1) Prioritize Compliance: Build a Global Certification + Local Filing System to Establish Market Entry Barriers

    1. Screen suppliers with top-tier credentials: Rigorously verify raw material suppliers’ FDA GRAS, EU Novel Food and ISO22000 food safety certifications. Mandate provision of Certificates of Analysis (CoA), Material Safety Data Sheets (MSDS) and heavy metal/microbiological test reports to eliminate uncertified raw materials;

    2. Complete local market filings in advance: Register products and audit labels for European and US markets to ensure full disclosure of ingredients, purity, efficacy claims, manufacturers and certification numbers aligned with FDA and EU regulations. For China market entry, complete Chinese label filings and bonded warehouse registration per Customs Decree No. 280;

    3. Establish centralized compliance archives: Retain all certification documents, test reports and procurement contracts to prepare for regulatory inspections and mitigate risks of product seizure or fines.

    (2) Empower Products with Technology: Focus on High Purity, High Absorption & Formulation Compatibility to Create Differentiated Offerings

    1. Match purity grades to end applications:

    o Health supplements: Source ≥99.5% pharmaceutical-grade raw materials to boost efficacy and brand premiums;

    o Cosmetics: Select ≥98.5% cosmetic-grade NMN with strict control of nicotinamide residue (≤0.1%) to prevent skin irritation;

    o Pet nutrition: Adopt ≥98% feed-grade material to balance cost and safety.

    2. Partner with suppliers holding proprietary delivery technologies: Procure pre-processed NMN with microencapsulation, liposomal wrapping or sustained-release treatments to immediately raise oral bioavailability above 38% without in-house R&D, creating proprietary technical barriers;

    3. Develop customized compound formulations:

    o Health supplements: Combine NMN with resveratrol and CoQ10 for multi-effect anti-aging blends;

    o Cosmetics: Integrate hyaluronic acid and collagen to enhance skin repair and hydration;

    o Pet nutrition: Pair NMN with fish oil and probiotics tailored to animal physiological needs.

    (3) Optimize Supply Chains: Implement Dual-Supplier Sourcing, Safety Stock & Fast-Delivery Mechanisms to Cut Costs & Mitigate Risks

    1. Adopt dual-supplier setup: Engage two qualified core suppliers (one primary, one backup). Primary suppliers guarantee stable mass production (≥50 tons annual capacity), while backup vendors offset capacity shortages and price surges to avoid production shutdowns;

    2. Rational safety stock management: Maintain 1–2 months of safety inventory prioritizing high-purity, fully certified raw materials. Source low-purity and niche SKUs on demand to reduce overstock;

    3. Shorten delivery lead times: Partner with suppliers with domestic factory stock and 7–14 day fast delivery to avoid lengthy 2–4 week overseas shipping cycles and accelerate end-market responsiveness;

    4. Refine cost control: Secure tiered volume discounts for orders ≥50kg; sign long-term 1+ year supply contracts with capped quarterly price fluctuations (≤5%) to hedge against raw material volatility.

    (4) Upgrade Brand & Channel Strategy: Penetrate Niche Segments & Execute Value-Driven Marketing to Lift Premiums & Repeat Purchase Rates

    1. Precise niche market positioning:

    o Health supplements: Target seniors and working professionals, emphasizing high purity and clinical validation;

    o Cosmetics: Highlight anti-aging repair and natural safety to align with luxury beauty channels;

    o Pet nutrition: Market pet longevity and anti-aging benefits via veterinary clinics and premium pet retailers.

    2. Replace price-focused marketing with value communication: Center marketing messaging on ≥99.5% purity, ≥38% bioavailability, official certifications and clinical data rather than low prices. Leverage KOL reviews, consumer testimonials and scientific research backing to build trust and brand premiums;

    3. Diversify channel layout:

    o Cross-border e-commerce: Prioritize Amazon and independent brand websites to avoid platform price competition;

    o Offline channels: Partner with luxury supermarkets, wellness centers and beauty salons to elevate brand positioning;

    o Private domain operations: Launch membership reward systems with exclusive perks to boost customer loyalty and repeat purchases.

    For more authentic, objective profiles of leading Chinese NMN Beta brands, contact HiSiaddi customer service.


    References
    We use cookies to optimise and personalise your experience, but you can choose to opt out of non-essential cookies.
    To find out more, read our Privacy Policy
    Reject All
    Accept All